𝔖 Bobbio Scriptorium

✦ LIBER ✦

Phase III randomized clinical trial of cisplatin plus paclitaxel vs the non-platinum chemotherapy doublet of topotecan plus paclitaxel in women with recurrent, persistent, or advanced cervical carcinoma: A Gynecologic Oncology Group study

✍ Scribed by Tewari, K.; Sill, M.; Monk, B.; Long, H.; Ramondetta, L.; Landrum, L.; Oaknin, A.; Reid, T.; Leitao, M.; Michael, H.

Book ID: 122776030
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 324 KB
Volume: 130
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2013.04.060

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III Trial of Doxorubicin Plus Cisp

Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

✍ Fleming, G. F. 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 194 KB

Phase III Study of Cisplatin With or Wit

Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

✍ Moore, D. H. 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 243 KB

Randomized phase III trial of tamoxifen

Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study

✍ Jean A. Hurteau; Mark F. Brady; Kathleen M. Darcy; William P. McGuire; Pamela Ed 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 490 KB

Paclitaxel plus cisplatin is as effectiv

Paclitaxel plus cisplatin is as effective as regimens containing gemcitabine in people with advanced non-small cell lung cancer: Abstracted from: Smit EF, van Meerbeeck JP, Lianes P, et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975. J Clin Oncol 2003;21:3909–17.

✍ Sarah Danson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB